![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Evaluation of: Lakatos PL, Czegledi Z, Szamosi T et al. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn’s disease. World J. Gastroenterology 15(28), 3504–3510 (2009).
Crohn’s disease (CD) is a chronic inflammatory bowel disease of uncertain etiology that is clinically heterogeneous and displays phenotypic change over time. With the advent of increasingly effective medical therapies, considerable research has focused on identifying patients at risk of developing a complicated course who could be targeted for early aggressive therapy. The evaluated paper identified several clinical factors associated with progression to complicated intestinal disease, including perianal disease, smoking, steroid use and early azathioprine therapy. In addition, it demonstrated that ileal disease, perianal disease, steroid use and smoking were associated with a more rapid progression to complicated disease. These results are consistent with previous work and provide evidence that early immunosuppressive use may potentially modify the natural history of CD in certain patients. The current role of clinical factors, serologic and genetic biomarkers in providing prognostic information in CD is discussed.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.